Diabetes Drug Appears to Fight Lung Cancer — But Only in Overweight or Obese Patients
Roswell Park Comprehensive Cancer CenterA widely accessible drug commonly used to control blood glucose levels in diabetic patients has the potential to strengthen the effects of immunotherapy and improve recurrence-free survival in people with lung cancer who are overweight or obese, according to a recently published article in the Journal of the National Cancer Institute.